PineBridge GEM II Updates IBEX Ltd Stake

TL;DR

PineBridge GEM II filed an amendment on their IBEX Ltd stake. Watch for more details.

AI Summary

PineBridge GEM II G.P., L.P. filed an amendment (No. 1) to its Schedule 13D on September 17, 2024, regarding its holdings in IBEX Limited. The filing indicates a change in the beneficial ownership of IBEX Limited's common shares, though specific new ownership percentages or dollar amounts are not detailed in this excerpt. The filing is an update to previous disclosures concerning their investment in the company.

Why It Matters

This filing signals a potential shift in the ownership structure or investment strategy of IBEX Limited, which could influence its stock performance and corporate direction.

Risk Assessment

Risk Level: medium — Schedule 13D filings, especially amendments, can indicate significant changes in major shareholder positions, potentially impacting stock volatility.

Key Players & Entities

• PineBridge GEM II G.P., L.P. (company) — Filer of the Schedule 13D amendment
• IBEX Limited (company) — Subject company of the filing
• William Corson (person) — Person authorized to receive notices

FAQ

Key Financial Figures

• $0.0001 — e of Issuer) Common Shares, par value $0.0001 (Title of Class of Securities) G4690

Filing Documents

• ef20035994_sc13da.htm (SC 13D/A) — 164KB
• ef20035994_ex5.htm (EX-99.5) — 8KB
• ef20035994_ex6.htm (EX-99.6) — 30KB
• image00024.jpg (GRAPHIC) — 18KB
• image00025.jpg (GRAPHIC) — 5KB
• 0001140361-24-041333.txt ( ) — 237KB

of the Schedule 13D is hereby amended and supplemented as follows

Item 1 of the Schedule 13D is hereby amended and supplemented as follows: This Amendment No. 1 to Schedule 13D ("Amendment No. 1") is being filed by the undersigned, pursuant to 240.13d-2(a), to amend and supplement the Schedule 13D filed with the U.S. Securities and Exchange Commission (the "SEC") on January 5, 2022 (together with this Amendment No. 1, the "Schedule 13D"), with respect to the common shares, $0.0001 par value (the "Common Shares"), of IBEX Limited (the "Issuer"), whose principal executive offices are located at 1717 Pennsylvania Avenue NW, Suite 825, Washington, DC 20006. Except as specifically provided herein, this Amendment No. 1 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined in this Amendment No. 1 shall have the meanings given to them in the Schedule 13D. Item 4. Purpose of Transaction

of the Schedule 13D is hereby amended and supplemented as follows

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On September 13, 2024, GEM II began effecting sales of Common Shares pursuant to a selling plan that is intended to satisfy the affirmative defense conditions set forth in Rule 10b5-1(c) under the Act (the "10b5-1 Plan"), which GEM II entered into with RBC Wealth Management on June 14, 2024. Under the terms of the 10b5-1 Plan, RBC Wealth Management may make periodic sales of up to an aggregate 300,000 Common Shares on behalf of GEM II, beginning on September 13, 2024 and terminating no later than September 12, 2025, and subject to applicable legal, regulatory and contractual limitations. The amount and timing of sales of Common Shares pursuant to the 10b5-1 Plan, if any, may vary and will be determined based on the terms of the 10b5-1 Plan, market conditions, including the market price of Common Shares, as well as other factors. The foregoing description of the 10b5-1 Plan is qualified in its entirety by reference to the 10b5-1 Plan, which is filed as Exhibit 6 to this Amendment No. 1 and is incorporated by reference herein. Item 5. Interest in Securities of the Issuer

(a) - (c) of the Schedule 13D is hereby amended and supplemented as follows

Item 5(a) - (c) of the Schedule 13D is hereby amended and supplemented as follows: (a) GEM II is the record owner of 1,959,739 Common Shares. As the sole director of PineBridge GEM II GP Ltd., which is the sole general partner of GEM II, GEM II GP may be deemed to beneficially own the Common Shares directly owned by GEM II. As members of the Investment Committee, each of the Investment Committee Members may be deemed to beneficially own the Common Shares directly owned by GEM II. PineBridge GEM II G.P., Co., a Cayman Islands company, is the sole general partner of GEM II GP. PineBridge GEM II G.P., Co. is a wholly-owned subsidiary of PineBridge Investments Partners LLC, a Delaware limited liability company that is a wholly-owned subsidiary of PineBridge Investments, L.P., a Cayman Islands partnership ("PILP"). The General Partner of PILP is Bridge Holdings Company Limited ("Bridge Holdings"). Bridge Holdings is wholly owned by Pacific Century Investment Holdings No. 1 Limited ("PCIH No. 1"). PCIH No. 1 is wholly owned by ChiltonLink Limited, which, in turn, is wholly owned by Richard Li. Each of PineBridge GEM II G.P., Co., PineBridge Investments Partners LLC, PILP, Bridge Holdings, PCIH No. 1, ChiltonLink Limited, and Richard Li. disclaims beneficial ownership of the Common Shares directly owned by GEM II. The percentage of outstanding Common Shares of the Issuer which may be deemed to be beneficially owned by each Reporting Person is set forth on Line 13 of such Reporting Person's cover sheet. Such percentage was calculated based on 16,803,198 Common Shares outstanding as of August 30, 2024, as reported on the Issuer's annual report on Form 10-K filed with the SEC on September 12, 2024. CUSIP No: G4690M101 SCHEDULE 13D Page 8 of 9 Pages (b) Regarding the number of shares as to which such person has: (i) sole power to vote or to direct the vote: See line 7 of cover sheets (ii) shared power to vote or to direct the vote: See line 8 of cover sheets

of the Schedule 13D is hereby amended and supplemented as follows

Item 6 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 4 of this Amendment No. 1 is incorporated by reference herein. Item 7. Material to be Filed as Exhibits

of the Schedule 13D is hereby amended and supplemented as follows

Item 7 of the Schedule 13D is hereby amended and supplemented as follows: Exhibit 5 Schedule of Transactions for Item 5(c) of Amendment No. 1. Exhibit 6 The 10b5-1 Plan. SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. EXECUTED this 17th day of September, 2024. PINEBRIDGE GLOBAL EMERGING MARKETS PARTNERS II, L.P. By: PINEBRIDGE GEM II GP Ltd., its General Partner By: PINEBRIDGE GEM II G.P., L.P., its Sole Director By: PINEBRIDGE GEM II G.P., Co., its General Partner By: /s/ John Leone Name: John Leone Title: Vice President PINEBRIDGE GEM II G.P., L.P. By: PINEBRIDGE GEM II G.P., Co., its General Partner By: /s/ John Leone Name: John Leone Title: Vice President /s/ John Leone John Leone * Pierre Mellinger * Kevin Clowe */s/ Lindsay Johnson Lindsay Johnson As attorney-in-fact *This Schedule 13D was executed by Lindsay Johnson on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached as an exhibit to the amendment to Form 3 filed by GEM II, GEM II GP, Mr. Mellinger and Mr. Clowe on July 13, 2023. Attention: Intentional misstatements or omissions of fact constitute federal violations (see 18 U.S.C. 1001).

View Full Filing

View this SC 13D/A filing on SEC EDGAR